Lam Research CorporationLRCX
Price$340.10Intrinsic value$207.9639% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $23.2B+26.0% YoYTTM through 28 Jun 2026
Net Income $7.3B+35.6% YoYTTM through 28 Jun 2026
Free Cash Flow $4.9BTTM through 28 Jun 2026

Margins

Current
Gross Margin49.8%
EBITDA Margin37.2%
Operating Margin35.0%
Net Margin31.3%

Returns

58.2%ROE
26.7%ROA
39.7%ROIC

Balance Sheet Health

Debt / Equity0.35x
Current Ratio2.54x
Net Debt-$1Bnet cash position
Cash & Equivalents$5.6B

Quality Metrics

Altman Z-Score25.82
Piotroski F-Score8 / 9
FCF Margin21.1%
Rule of 4070.7
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'20'21'22'23'24'25'26
FY2026: $23.2B
Diluted EPS$5.76TTM
'20'21'22'23'24'25'26
FY2026: $5.76

Dividend

$0.52Per share, FY20260.27%Yield-1.5%5-yr growth

Capital Allocation

R&D Spend$2.4B
Capex Intensity4.2%

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.